Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
10,388 total articles
VEON Ltd., a Nasdaq-listed global digital operator, will release its financial and operating results for Q1 2026 on May 13, 2026. The company will host a conference call and livestream to provide insights, with enhanced shareholder engagement through a Q&A platform beginning May 6, 2026.
Trevi Therapeutics priced an underwritten public offering of 11.6 million shares at $13.00 per share, aiming to raise approximately $150 million before expenses. The proceeds will support ongoing clinical development of its investigational therapy Haduvio (oral nalbuphine ER) targeting chronic cough in patients with interstitial lung diseases.
HII announced at the 2026 Sea-Air-Space Expo a new distributed maritime operations framework integrating manned and autonomous systems, open architecture technologies, and modular payloads to support the U.S. Navy's Hedge Strategy. The approach promotes interoperability across maritime, air, space, cyber, and land domains using HII's Minotaur Missi…
nVent Electric plc, a leader in electrical connection and protection solutions, will announce its first quarter 2026 financial results on May 1, 2026. The company will provide earnings details on its website and conduct a conference call with investors to discuss the results.
Fortuna Mining Corp. announced the renewal of its normal course issuer bid (NCIB) authorizing the repurchase of up to 15.2 million common shares, representing 5% of outstanding shares, starting May 4, 2026. The company will repurchase shares on the NYSE and cancel them, aiming to enhance shareholder value by buying back shares trading below their i…
Kyivstar Group Ltd., the first Ukrainian company listed on Nasdaq, announced it will release its first quarter 2026 earnings and operational results on May 13, 2026. The company also announced a follow-up conference call on May 14 to discuss these results with senior management. Kyivstar is a leading digital operator in Ukraine providing mobile, fi…
Toll Brothers, a leading luxury home builder, announced the final home for sale at its Freestone Station community in Marietta, Georgia. This quick move-in 5-bedroom, 4-bath Hillside Farmhouse home is priced at $824,000 and will be completed by May 2026. The community offers premium amenities and convenient access to major highways and local attrac…
Dime Community Bancshares, a New York State-chartered trust company with $15 billion in assets and leading deposit market share on Greater Long Island, will release its Q1 2026 earnings on April 23 before U.S. markets open. The CEO will discuss financial results on a conference call with Q&A, accessible via webcast and telephone. A replay will be a…
Kura Oncology reported encouraging preliminary data from a subset analysis of its ongoing FIT-001 clinical trial combining darlifarnib with cabozantinib in patients with clear cell renal cell carcinoma (ccRCC) previously treated with cabozantinib. The combination demonstrated a 44% objective response rate and 94% disease control rate, with tumor sh…
Immuron Limited announced unaudited Q3 sales growth of 16% globally for Travelan®, an over-the-counter immunotherapy product targeting gastrointestinal pathogens. Growth was driven by increased brand awareness and marketing in Australia, steady advancements in U.S. sales despite currency headwinds, and significant gains in Canadian retail penetrati…
MiNK Therapeutics announced Phase II trial results showing their cell therapy agenT-797, combined with botensilimab and balstilimab, achieved a 77% disease control rate and durable survival beyond 20 months in patients with advanced PD-1 refractory gastroesophageal cancer. An induction treatment strategy yielded significant improvements in progress…
Zymeworks Inc. disclosed multiple new preclinical and clinical data sets at the AACR 2026 meeting, highlighting its advanced antibody-drug conjugate (ADC) programs targeting difficult-to-treat cancers, including RAS-mutated tumors. Key presentations showcased efficacy, tumor-selective delivery, and favorable tolerability of novel ADCs such as ZW191…
Atour Lifestyle Holdings Limited, a leading Chinese lifestyle group operating in hospitality and retail sectors, announced the filing of its annual report on Form 20-F for the fiscal year ended December 31, 2025. The report is accessible on the company's investor website and the SEC's website, with hard copies available upon request.
Zentalis Pharmaceuticals announced encouraging preclinical results for its WEE1 inhibitor, azenosertib, showing efficacy in triple-negative breast cancer (TNBC) models resistant to antibody-drug conjugates. Additionally, real-world data reveal poor outcomes for Cyclin E1-positive ovarian cancer patients under current treatments, emphasizing the unm…
Surgery Partners, Inc., a leading outpatient surgical services provider, announced that it will release its first quarter 2026 earnings before market open on May 5, 2026, followed by a conference call the same day. The company provides high-quality, cost-effective surgical and ancillary care through over 200 locations in 30 states.
Akamai Technologies announced that MediaMelon, a streaming intelligence company, has joined its Qualified Compute Partner Program as an Independent Software Vendor. MediaMelon's SmartSight platform, providing real-time video streaming analytics and AI-powered insights, will now be integrated and scaled on Akamai's globally distributed cloud. This p…
KANZHUN LIMITED, trading as BOSS Zhipin, announced continued share repurchases in 2026 totaling over RMB896 million, demonstrating its strong commitment to enhancing shareholder returns through its ongoing buyback program.
Essent Group Ltd., a Bermuda-based holding company providing private mortgage insurance, reinsurance, and title insurance services, announced it will hold a conference call to discuss its Q1 2026 financial results on May 8, 2026. The results will be released before market open that day, with the call accessible both via webcast and phone.
TTEC Holdings, Inc., a global consulting, technology, and managed services company, announced it will release its first quarter 2026 earnings results on May 7, 2026, followed by a webcasted investor conference call on May 8, 2026. The earnings release and webcast provide investors an opportunity to assess the company's financial performance and fut…
CAMP4 Therapeutics Corporation reported that its Compensation Committee granted inducement stock options totaling 43,000 shares to three newly hired employees. These options have a ten-year term, an exercise price equal to the closing stock price on the grant date ($4.59), and vest over four years, designed to incentivize talent acquisition and ret…
Talen Energy Corporation has priced $4 billion in senior notes due 2031 and 2033 to finance its acquisition of 2,451 MW of power generation capacity and redeem existing higher-coupon debt. The move supports the company's expansion with additional fossil and nuclear assets, strengthening its position in the U.S. power generation market.
BioXcel Therapeutics announced a virtual event focused on their commercial launch plan for IGALMI®, targeting the treatment of acute agitation associated with bipolar disorder and schizophrenia in the at-home setting, ahead of the November 14 PDUFA date. Market assessment highlights a significant opportunity with up to 86 million annual addressable…
Pyxis Oncology announced new preclinical data demonstrating that its lead candidate, micvotabart pelidotin (MICVO), a novel antibody-drug conjugate, shows significant anti-tumor activity as monotherapy and synergistic effects when combined with anti-PD-1 therapy in a head and neck squamous cell carcinoma (HNSCC) model. These findings support ongoin…
Applied Optoelectronics, Inc. is expanding its Houston-area facilities by adding two adjacent buildings in Pearland, Texas, increasing its manufacturing capacity by about 388,000 square feet. This move supports the company’s ambitious 2027 capacity targets and positions AOI to scale production of high-speed optical transceivers and laser fabricatio…
ORIC Pharmaceuticals announced the presentation of multiple preclinical data posters at the 2026 AACR Annual Meeting demonstrating the potential of their drug candidate rinzimetostat, an allosteric PRC2 inhibitor, to treat prostate cancer, including treatment-resistant forms. The data indicates strong antitumor activity across prostate cancer model…
